{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:25:36Z","timestamp":1774448736801,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-017-0567-5","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T11:47:33Z","timestamp":1495453653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The use of Macitentan in Fontan circulation: a case report"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5959-6628","authenticated-orcid":false,"given":"Polyvios","family":"Demetriades","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Condliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Bowater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul F.","family":"Clift","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,22]]},"reference":[{"key":"567_CR1","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1161\/CIRCULATIONAHA.114.013365","volume":"130","author":"DJ Goldberg","year":"2014","unstructured":"Goldberg DJ, Paridon SM. Fontan circulation: the search for targeted therapy. Circulation. 2014;130:1999\u20132001.","journal-title":"Circulation"},{"key":"567_CR2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/heartjnl-2015-307467","volume":"102","author":"M Gewillig","year":"2016","unstructured":"Gewillig M, Brown SC. The Fontan circulation after 45\u2005years: update in physiology. Heart. 2016;102:1081\u20136.","journal-title":"Heart"},{"issue":"2","key":"567_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1067\/mtc.2002.119697","volume":"123","author":"M L\u00e9vy","year":"2002","unstructured":"L\u00e9vy M, Danel C, Tamisier D, Vouh\u00e9 P, Leca F. Histomorphometric analysis of pulmonary vessels in single ventricle for better selection of patients for the Fontan operation. J Thorac Cardiovasc Surg. 2002;123(2):263\u201370.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"567_CR4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jtcvs.2004.07.013","volume":"128","author":"MB Mitchell","year":"2004","unstructured":"Mitchell MB, Campbell DN, Ivy D, Boucek MM, Sondheimer HM, Pietra B, Das BB, Coll JR. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. J Thorac Cardiovasc Surg. 2004;128(5):693\u2013702.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"567_CR5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1747-0803.2012.00635.x","volume":"7","author":"SE Bowater","year":"2012","unstructured":"Bowater SE, Weaver RA, Thorne SA, Clift PF. The safety and effects of bosentan in patients with a Fontan circulation (MHRA 2005-005898-29). Congenit Heart Dis. 2012;7:243\u20139.","journal-title":"Congenit Heart Dis"},{"key":"567_CR6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3345\/kjp.2014.57.10.461","volume":"57","author":"YH Kim","year":"2014","unstructured":"Kim YH, Chae MH, Choi DY. Inhaled iloprost for the treatment of patient with Fontan circulation. Korean J Pediatr. 2014;57:461\u20133.","journal-title":"Korean J Pediatr"},{"key":"567_CR7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/eurheartj\/ehn215","volume":"29","author":"A Giardini","year":"2008","unstructured":"Giardini A, et al. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J. 2008;29:1681\u20137.","journal-title":"Eur Heart J"},{"key":"567_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0976-500X.149151","volume":"6","author":"A Khadka","year":"2015","unstructured":"Khadka A, Singh Brashier DB, Tejus A, Sharma AK. Macitentan: an important addition to the treatment of pulmonary arterial hypertension. J Pharmacol Pharmacother. 2015;6:53\u20137.","journal-title":"J Pharmacol Pharmacother"},{"issue":"1","key":"567_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.chest.2016.08.1473","volume":"151","author":"S Mehta","year":"2017","unstructured":"Mehta S, et al. Macitentan improves health-related quality of life for patients with pulmonary arterial hypertension: results from the randomized controlled SERAPHIN trial. Chest. 2017;151(1):106\u201318.","journal-title":"Chest"},{"key":"567_CR10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00408-016-9928-6","volume":"194","author":"M Kuntz","year":"2016","unstructured":"Kuntz M, Leiva-Juarez MM, Luthra S. Systematic review of randomized controlled trials of Endothelin receptor antagonists for pulmonary arterial hypertension. Lung. 2016;194:723\u201332.","journal-title":"Lung"},{"key":"567_CR11","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.113.008441","volume":"130","author":"A Hebert","year":"2014","unstructured":"Hebert A, et al. Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (treatment with Endothelin receptor antagonist in Fontan patients, a randomized, placebo-controlled, double-blind study measuring peak oxygen consumption) study. Circulation. 2014;130:2021\u201330.","journal-title":"Circulation"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-017-0567-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T11:47:35Z","timestamp":1495453655000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-017-0567-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,22]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1186\/s12872-017-0567-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,22]]},"article-number":"131"}}